A carregar...
Premature phase II study of amrubicin as palliative chemotherapy for previously treated malignant pleural mesothelioma
BACKGROUND: Treatment options for malignant pleural mesothelioma (MPM) are limited. Anthracyclines are considered key drugs for treating MPM. However, their use is limited by severe cardiac toxicities. Amrubicin (AMR) is a next‐generation anthracycline that is commonly used to treat lung cancer. Her...
Na minha lista:
| Publicado no: | Thorac Cancer |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons Australia, Ltd
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8169308/ https://ncbi.nlm.nih.gov/pubmed/33830645 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13892 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|